Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 2281 AL 2295

Prediction of clinical diagnosis of Alzheimer's disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years

Stocker H, Perna L, Weigl K, Möllers T, Schöttker B, Thomsen H, Holleczek B, Rujescu D, Brenner H.

Mol Psychiatry. 2021 Oct;26(10):5812-5822. doi: 10.1038/s41380-020-0764-y. Epub 2020 May 13.

Artificial intelligence and neuropsychological measures: The case of Alzheimer's disease

Battista P, Salvatore C, Berlingeri M, Cerasa A, Castiglioni I.

Neurosci Biobehav Rev. 2020 Jul;114:211-228. doi: 10.1016/j.neubiorev.2020.04.026. Epub 2020 May 11.

Editorial: Screening for Mild Cognitive Impairment: There Is the Will but Is There a Way?

Galvin JE.

J Prev Alzheimers Dis. 2020;7(3):144-145. doi: 10.14283/jpad.2020.16.

Rationale for Early Diagnosis of Mild Cognitive Impairment (MCI) Supported by Emerging Digital Technologies

Sabbagh MN, Boada M, Borson S, Chilukuri M, Doraiswamy PM, Dubois B, Ingram J, Iwata A, Porsteinsson AP, Possin KL, Rabinovici GD, Vellas B, Chao S, Vergallo A, Hampel H.

J Prev Alzheimers Dis. 2020;7(3):158-164. doi: 10.14283/jpad.2020.19.

Early Detection of Mild Cognitive Impairment (MCI) in an At-Home Setting

Sabbagh MN, Boada M, Borson S, Doraiswamy PM, Dubois B, Ingram J, Iwata A, Porsteinsson AP, Possin KL, Rabinovici GD, Vellas B, Chao S, Vergallo A, Hampel H.

J Prev Alzheimers Dis. 2020;7(3):171-178. doi: 10.14283/jpad.2020.22.

Brief Cognitive Tests in the Case of Dementia and Alzheimer's Disease Early Diagnosis

Sagiadinou M, Plerou A.

Adv Exp Med Biol. 2020;1195:127-135. doi: 10.1007/978-3-030-32633-3_17.

Neuropsychiatric symptoms as prognostic makers for the elderly with mild cognitive impairment: a meta-analysis

Hu M, Shu X, Wu X, Chen F, Hu H, Zhang J, Yan P, Feng H.

J Affect Disord. 2020 Jun 15;271:185-192. doi: 10.1016/j.jad.2020.03.061. Epub 2020 Apr 18.

Management of cognitive decline in Alzheimer's disease using a non-pharmacological intervention program: A case report

Quail Z, Carter MM, Wei A, Li X.

Medicine (Baltimore). 2020 May 22;99(21):e20128. doi: 10.1097/MD.0000000000020128.

Assessment of visually guided reaching in prodromal Alzheimer's disease: a cross-sectional study protocol

Mitchell AG, McIntosh RD, Rossit S, Hornberger M, Pal S.

BMJ Open. 2020 Jun 4;10(6):e035021. doi: 10.1136/bmjopen-2019-035021.

Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs

Millan MJ, Dekeyne A, Gobert A, Brocco M, Mannoury la Cour C, Ortuno JC, Watson D, Fone KCF.

Neuropharmacology. 2020 Oct 15;177:108099. doi: 10.1016/j.neuropharm.2020.108099. Epub 2020 Jun 7.

Plasma Clusterin as a Potential Link Between Diabetes and Alzheimer Disease

Ha J, Moon MK, Kim H, Park M, Cho SY, Lee J, Lee JY, Kim E.

J Clin Endocrinol Metab. 2020 Sep 1;105(9):dgaa378. doi: 10.1210/clinem/dgaa378.

Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial

Craft S, Raman R, Chow TW, Rafii MS, Sun CK, Rissman RA, Donohue MC, Brewer JB, Jenkins C, Harless K, Gessert D, Aisen PS.

JAMA Neurol. 2020 Sep 1;77(9):1099-1109. doi: 10.1001/jamaneurol.2020.1840.

APOE ε4 allele accelerates age-related multi-cognitive decline and white matter damage in non-demented elderly

Sun J, Zhu Z, Chen K, Wei D, Li X, Li H, Zhang J, Chen X, Chen Y, Zhang Z.

Aging (Albany NY). 2020 Jun 22;12(12):12019-12031. doi: 10.18632/aging.103367. Epub 2020 Jun 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias